Skip to main content
SpringerLink
Log in

Generic Dabigatran for Cancer-Associated Venous Thromboembolism: Real-World Data

  • CORRESPONDENCE
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Khorana AA, Mackman N, Falanga A, Pabinger I, Noble S, Ageno W et al (2022) Cancer-associated venous thromboembolism. Nat Rev Dis Primer 8:1–18

    Article  Google Scholar 

  2. Ganetsky M, Babu KM, Salhanick SD, Brown RS, Boyer EW (2011) Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. J Med Toxicol 7:281–287

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Desai R, Koipallil GK, Thomas N, Mhaskar R, Visweshwar N, Laber D et al (2020) Efficacy and safety of direct oral anticoagulants for secondary prevention of cancer associated thrombosis: a meta-analysis of randomized controlled trials. Sci Rep 10:18945

    Article  PubMed  PubMed Central  Google Scholar 

  4. Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK, Khorana AA et al (2021) American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv 5:927–974

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Falanga A, Ay C, Nisio MD, Gerotziafas G, Jara-Palomares L, Langer F et al (2023) Venous thromboembolism in cancer patients: ESMO clinical practice guideline. Ann Oncol 34:452–467

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

None

Funding

No external sources of funding.

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Regional Cancer Center, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), 3rd Floor, SSB, Dhanvantari Nagar, Puducherry, 605006, India

    Fen Saj, Smita Kayal, Biswajit Dubashi & Prasanth Ganesan

Authors
  1. Fen Saj
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Smita Kayal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Biswajit Dubashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Prasanth Ganesan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Prasanth Ganesan.

Ethics declarations

Conflict of interest

No relevant conflicts of interests to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saj, F., Kayal, S., Dubashi, B. et al. Generic Dabigatran for Cancer-Associated Venous Thromboembolism: Real-World Data. Indian J Hematol Blood Transfus (2024). https://doi.org/10.1007/s12288-024-01745-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12288-024-01745-7

Search

Navigation